Literature DB >> 24944498

Impairment of gastrointestinal quality of life in severely obese patients.

Po-Jui Yu1, Ju-Juin Tsou1, Wei-Jei Lee1, Kuo-Ting Lee1, Yi-Chih Lee1.   

Abstract

AIM: To investigate the common gastro-intestinal symptoms and quality of life in severely obese subjects.
METHODS: We prospectively recruited 340 severely obese patients [mean age 30.5 ± 7.8 years; mean body mass index (BMI) 42.9 ± 6.1 kg/m(2)] and 340 healthy persons (mean BMI 23.1 ± 3.8 kg/m(2)) matched in sex, age, marriage and education. The quality of life was studied using a specific gastrointestinal quality of life index (GIQLI) questionnaire. The 36 items and four functional domains of the GIQLI were compared and analyzed between the groups. The possible correlation of GIQLI scores with specific clinical variables in severely obese patients was assessed by measuring Pearson's coefficient of correlation.
RESULTS: The mean GIQLI score of severely obese patients was lower than the normal control group (108.5 ± 17.1 vs 123.2 ± 14.8, P < 0.01). Severely obese patients had decreased scores in the domains of general health, including physical (17.3 ± 6.0 vs 22.4 ± 3.1, P < 0.01), emotional (12.6 ± 4.3 vs 16.6 ± 3.1, P < 0.01) and social function (14.7 ± 3.9 vs 17.9 ± 2.5, P < 0.01), and in the domain of gastrointestinal symptoms (63.9 ± 6.7 vs 66.3 ± 7.2, P < 0.05). A significantly decreased score was found in nine items, and there was an increased score in one out of the 19 items in the domain of symptoms of the GIQLI questionnaire. The decreased score in the domain of symptoms was correlated with increasing glycosylated hemoglobin (HbA1c) levels.
CONCLUSION: Severe obesity resulted in a significant impairment of the quality of life and caused specific gastrointestinal symptoms compared with normal controls. The development of gastrointestinal symptoms is correlated increasing HbA1c, suggesting that a poor control of hyperglycemia might be the etiology.

Entities:  

Keywords:  Gastro-intestinal symptoms; Glycosylated hemoglobin; Quality of life; Severe obesity

Mesh:

Substances:

Year:  2014        PMID: 24944498      PMCID: PMC4051947          DOI: 10.3748/wjg.v20.i22.7027

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Bariatric surgery: Asia-Pacific perspective.

Authors:  Wei-Jei Lee; Weu Wang
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

2.  Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial.

Authors:  Gavitt A Woodard; Betsy Encarnacion; John R Downey; Joseph Peraza; Karen Chong; Tina Hernandez-Boussard; John M Morton
Journal:  J Gastrointest Surg       Date:  2009-04-18       Impact factor: 3.452

3.  Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia.

Authors:  Wei-Jei Lee; Weu Wang; Po-Jui Yu; Po-Li Wei; Ming-Te Huang
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

4.  Microbial ecology: human gut microbes associated with obesity.

Authors:  Ruth E Ley; Peter J Turnbaugh; Samuel Klein; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  The impact of obesity on health-related quality-of-life in the general adult US population.

Authors:  Haomiao Jia; Erica I Lubetkin
Journal:  J Public Health (Oxf)       Date:  2005-04-08       Impact factor: 2.341

6.  Body-mass index and mortality in a prospective cohort of U.S. adults.

Authors:  E E Calle; M J Thun; J M Petrelli; C Rodriguez; C W Heath
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

7.  Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.

Authors:  Howard Hampel; Neena S Abraham; Hashem B El-Serag
Journal:  Ann Intern Med       Date:  2005-08-02       Impact factor: 25.391

8.  Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Authors:  Phui-Ly Liew; Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Wei-Yu Chen; Chia-Lang Fang; Ming-Te Huang
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

Review 9.  Probiotic agents in the treatment of irritable bowel syndrome.

Authors:  M Guslandi
Journal:  J Int Med Res       Date:  2007 Sep-Oct       Impact factor: 1.671

10.  Obesity alters gut microbial ecology.

Authors:  Ruth E Ley; Fredrik Bäckhed; Peter Turnbaugh; Catherine A Lozupone; Robin D Knight; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-20       Impact factor: 11.205

View more
  3 in total

1.  Medium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass.

Authors:  Wei-Jei Lee; Eng-Hong Pok; Abdullah Almulaifi; Ju Juin Tsou; Kong-Han Ser; Yi-Chih Lee
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

2.  Gastro-intestinal Quality of Life After Metabolic Surgery for the Treatment of Type 2 Diabetes Mellitus.

Authors:  Wei-Jei Lee; Ming-Hsien Lee; Po-Jui Yu; Jih-Hua Wei; Keong Chong; Shu-Chun Chen; Abdullah Almulaifi; Yi-Chih Lee
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

3.  Gastrointestinal Quality of Life Improves Significantly After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass-a Prospective Cross-Sectional Study Within a 2-Year Follow-up.

Authors:  Felix Nickel; Lukas Schmidt; Thomas Bruckner; Adrian T Billeter; Hannes G Kenngott; Beat-Peter Müller-Stich; Lars Fischer
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.